Bentham Science Logo

Track Your Manuscript:

Current Drug Targets

Volume 23, 17 Issues, 2022
ISSN: 1873-5592 (Online)
ISSN: 1389-4501 (Print)
This journal supports open access


Current Drug Targets , Volume 10 - Number 4

Triacylglycerol Metabolism

, 10(4): 302 - 319

Haralabos C. Karantonis, Tzortzis Nomikos and Constantinos A. Demopoulos

DOI: 10.2174/138945009787846443

Triglycerides and Vascular Risk: Insights from Epidemiological Data and Interventional Studies

, 10(4): 320 - 327

Konstantinos Tziomalos, Vasilios G. Athyros, Asterios Karagiannis, Genovefa D. Kolovou and Dimitri P. Mikhailidis

DOI: 10.2174/138945009787846425

Primary and Secondary Hypertriglyceridaemia

, 10(4): 336 - 343

Genovefa D. Kolovou, Katherine K. Anagnostopoulou, Peggy M. Kostakou, Helen Bilianou and Dimitri P. Mikhailidis

DOI: 10.2174/138945009787846452

Influence of Lifestyle Measures on Hypertriglyceridaemia

, 10(4): 344 - 355

F. Manfredini, S. D'Addato, L. Laghi, A. M. Malagoni, S. Mandini, B. Boari, C. Borghi and R. Manfredini

DOI: 10.2174/138945009787846407

Chalcones Derivatives Acting as Cell Cycle Blockers: Potential Anti Cancer Drugs?

, 10(4): 363 - 371

Boumendjel Ahcene, Ronot Xavier, Boutonnat Jean, Ahcene Boumendjel, Xavier Ronot and Jean Boutonnat

DOI: 10.2174/138945009787846416


Francis J. Castellino
(14643 citations)
Dean Emeritus, College of Science,
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556
View Full Editorial Board

COPE Compliant

Cope Logo

Journal History

Current Drug Targets Journal was launched in 2000. Dr. Francis J. Castellino serves as the Editor-in-Chief of the journal.

Related Journals

Related eBooks

eBooks Catalog